Document Type : Original Article

Authors

1 Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran

2 Department of Pediatrics, Birjand University of Medical Sciences, Birjand, Iran

3 Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran

Abstract

BACKGROUND: Congenital heart defects (CHDs) are common anomalies in children. Cardiopulmonary bypass (CPB) is widely used in cardiac surgeries, but it is associated with complications. Liver and kidney injuries frequently occur during CPB. This study aimed to evaluate liver and kidney damage in pediatric patients with CHDs undergoing cardiac surgery with CPB.
METHODS: This retrospective study examined 51 patients with CHDs who underwent cardiac surgery with CPB at Vali-Asr and Razi hospitals in Birjand, Iran. The study period spanned from 2013 to 2019. Patient information was extracted from hospital records and compiled into checklists, which included demographic data, disease severity, liver function tests, cardiac ejection fraction, and serum levels of hematocrit, direct and indirect bilirubin, albumin, total protein, and creatinine.
RESULTS: Among the patients, 52.9% were male and 47.1% were female, with a mean age of 37 months. A total of 78.4% had cyanotic CHDs.
After surgery, the levels of AST, ALT, and ALKP increased significantly (P < 0.001), while the levels of indirect bilirubin, albumin, and total protein decreased (P < 0.001). The cardiac ejection fraction also improved following surgery (P < 0.001). However, changes in creatinine and direct bilirubin were not significant. Notably, AST levels were markedly higher in deceased patients compared to survivors.
CONCLUSION: This study revealed significant alterations in liver enzyme levels in patients undergoing cardiac surgery using CPB, potentially indicating liver damage during the procedure. Furthermore, elevated postoperative AST levels were associated with a higher risk of mortality.

Keywords

1. Sharma SK, Madhusmita Acharya MA, Sahoo SC, Panda PK. Prevalence of congenital heart disease in sick neonates: an echocardiographic evaluation. Ann Int Med Den Res. 2018;4(3):CD05-8.
2. Remington JS, Wilson CB, Nizet V, Klein JO, Maldonado Y. Infectious diseases of the fetus and newborn E-book. Elsevier Health Sciences; 2010 Aug 27.
3. Houyel L, Meilhac SM. Heart Development and Congenital Structural Heart Defects. Annu Rev Genomics Hum Genet. 2021 Aug 31;22:257-84. https://doi.org/10.1146/annurev-genom-083118-015012
4. Sun R, Liu M, Lu L, Zheng Y, Zhang P. Congenital Heart Disease: Causes, Diagnosis, Symptoms, and Treatments. Cell Biochem Biophys. 2015 Jul;72(3):857-60. https://doi.org/10.1007/s12013-015-0551-6
5. Baehner T, Boehm O, Probst C, Poetzsch B, Hoeft A, Baumgarten G, et al. Kardiopulmonaler bypass in der herzchirurgie [Cardiopulmonary bypass in cardiac surgery]. Anaesthesist. 2012 Oct;61(10):846-56. https://doi.org/10.1007/s00101-012-2050-0
6. DeFoe GR, Ross CS, Olmstead EM, Surgenor SD, Fillinger MP, Groom RC, et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg. 2001 Mar;71(3):769-76. https://doi.org/10.1016/s0003-4975(00)02393-6
7. Sharma P, Ananthanarayanan C, Vaidhya N, Malhotra A, Shah K, Sharma R. Hyperbilirubinemia after cardiac surgery: An observational study. Asian Cardiovasc Thorac Ann. 2015 Nov;23(9):1039-43. https://doi.org/10.1177/0218492315607149
8. McSweeney ME, Garwood S, Levin J, Marino MR, Wang SX, Kardatzke D, et al. Adverse Gastrointestinal Complications After Cardiopu-lmonary Bypass: Can Outcome Be Predicted from Preoperative Risk Factors? Anesth Analg. 2004 Jun;98(6):1610-7. https://doi.org/10.1213/01.ane.0000113556.40345.2e
9. Yamada T, Ochiai R, Takeda J, Kikuchi H, Ishibashi M, Watanabe K. Off-pump coronary artery bypass attenuates transient hepatocellular damage after myocardial revascularization. J Cardiothorac Vasc Anesth. 2005 Oct;19(5):603-7. https://doi.org/10.1053/j.jvca.2005.02.004
10. Shahbazi S, Panah A, Sahmeddini MA. Evaluation of factors influencing liver function test in on-pump coronary artery bypass graft surgery. Iran J Med Sci. 2013 Dec;38(4):308-13.
11. Bobillo-Perez S, Jordan I, Corniero P, Balaguer M, Sole-Ribalta A, Esteban ME, et al. Prognostic value of biomarkers after cardiopulmonary bypass in pediatrics: The prospective PANCAP study. PLoS One. 2019 Jun 17;14(6):e0215690. https://doi.org/10.1371/journal.pone.0215690
12. Kehl T, Biermann D, Briem-Richter A, Schoen G, Olfe J, Sachweh JS, et al. Impact of hepatopathy in pediatric patients after surgery for complex congenital heart disease. PLoS One. 2021 Mar 25;16(3):e0248776. https://doi.org/10.1371/journal.pone.0248776
13. Lassnigg A, Schmid ER, Hiesmayr M, Falk C, Druml W, Bauer P, et al. Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med. 2008 Apr;36(4):1129-37. https://doi.org/10.1097/ccm.0b013e318169181a
14. Sabzi F, Faraji R. Liver Function Tests Following Open Cardiac Surgery. J Cardiovasc Thorac Res. 2015;7(2):49-54. https://doi.org/10.15171/jcvtr.2015.11
15. Golitaleb M, Haghazali M, Golaghaie F, Ghadrdoost B, Sahebi A, Kargar F. Changes in liver enzymes in the patients undergoing open cardiac surgery and related factors. Int J Adv Biotechnol Res. 2017 Jan 1;8(3):2086-91.
16. Song J, Kim K, Huh J, Kang IS, Kim SH, Yang JH, et al. Imaging Assessment of Hepatic Changes after Fontan Surgery. Int Heart J. 2018 Sep 26;59(5):1008-14. https://doi.org/10.1536/ihj.17-349
17. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004 Nov-Dec;17(6):432-7. https://doi.org/10.1111/j.0894-0959.2004.17603.x
18. Kapoor PM, Narula J, Chowdhury UK, Kiran U, Taneja S. Serum albumin perturbations in cyanotics after cardiac surgery: Patterns and predictions. Ann Card Anaesth. 2016 Apr-Jun;19(2):300-5. https://doi.org/10.4103/0971-9784.179633
19. Hanley C, Callum J, Karkouti K, Bartoszko J. Albumin in adult cardiac surgery: a narrative review. Can J Anaesth. 2021 Aug;68(8):1197-213. https://doi.org/10.1007/s12630-021-01991-7
20. Xu R, Hao M, Zhou W, Liu M, Wei Y, Xu J, et al. Preoperative hypoalbuminemia in patients undergoing cardiac surgery: a meta-analysis. Surg Today. 2023 Aug;53(8):861-72. https://doi.org/10.1007/s00595-022-02566-9
21. Udeh CI, You J, Wanek MR, Dalton J, Udeh BL, Demirjian S, et al. Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor? Perioper Med (Lond). 2018 Dec 14;7:29. https://doi.org/10.1186/s13741-018-0110-y
22. Long JB, Engorn BM, Hill KD, Feng L, Chiswell K, Jacobs ML, et al. Postoperative Hematocrit and Adverse Outcomes in Pediatric Cardiac Surgery Patients: A Cross-Sectional Study From the Society of Thoracic Surgeons and Congenital Cardiac Anesthesia Society Database Collaboration. Anesth Analg. 2021 Nov 1;133(5):1077-88. https://doi.org/10.1213/ane.0000000000005416
23. Agbani EO, Poole AW. Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis. Blood. 2017 Nov 16;130(20):2171-79. https://doi.org/10.1182/blood-2017-05-787259
24. Yuan SM. Acute kidney injury after pediatric cardiac surgery. Pediatr Neonatol. 2019 Feb;60(1):3-11. https://doi.org/10.1016/j.pedneo.2018.03.007
25. Yu Y, Li C, Zhu S, Jin L, Hu Y, Ling X, et al. Diagnosis, pathophysiology and preventive strategies for cardiac surgery-associated acute kidney injury: a narrative review. Eur J Med Res. 2023 Jan 24;28(1):45. https://doi.org/10.1186/s40001-023-00990-2
26. Sameema VV, Soni K, Deora S, Sharma JB, Choudhury B, Kaushal D, et al. Assessment of preoperative and postoperative cardiac function in children with adenotonsillar hypertrophy: a prospective cohort study. Eur Arch Otorhinolaryngol. 2022 Jun;279(6):3013-19. https://doi.org/10.1007/s00405-022-07255-4
27. Wang S, Cheng S, Zhang Y, Lyu Y, Liu J. Extent of Ejection Fraction Improvement After Revascularization Associated with Outcomes Among Patients with Ischemic Left Ventricular Dysfunction. Int J Gen Med. 2022 Sep 13;15:7219-28. https://doi.org/10.2147/ijgm.s380276